Eargo To Pay $34M+ To Resolve False-Claims Allegations
Executive Summary
The company, which denies the allegations, allegedly sold hearing aids to federal employees and billed a government insurance plan without the required hearing assessment.
You may also be interested in...
Senators, State AGs Differ On Whether Further Federal Regulation Needed For OTC Hearing Aids
Sens. Warren and Grassley say federal regulation is needed to ensure consumers in all states benefit from OTC hearing aids. State AGs, on the other hand, have asked the FDA to “define preemption terms in a way that recognizes the important role state and local entities play in protecting consumers.”
Hearing Aid Maker Eargo Target Of US DOJ Investigation
Directly billing insurers for over-the-counter hearing aids may have triggered federal concern, a financial analysis firm says.
Joint Mission: FDA And VA Partner On Device Development Initiative
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.